References
Original article
Voors, A. A. et al. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat. Med. https://doi.org/10.1038/s41591-021-01659-1 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, G.B. Benefit of empagliflozin in acute heart failure. Nat Rev Cardiol 19, 286 (2022). https://doi.org/10.1038/s41569-022-00693-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-022-00693-x
- Springer Nature Limited